Catella Healthcare Investments
1
9M
1
0.03
1
- Areas of investment
Summary
In 1989 was created Catella Healthcare Investments, which is appeared as VC. The venture was found in Europe in Sweden. The main office of represented VC is situated in the Stockholm.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Catella Healthcare Investments, startups are often financed by TL Ventures, Frazier Healthcare Partners, InterWest Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, T. Rowe Price, T-bolaget.
The higher amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2005. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Among the most successful fund investment fields, there are Biotechnology, Pharmaceutical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline QuatRx Pharmaceuticals, Cellartis For fund there is a match between the country of its foundation and the country of its the most frequent investments - Sweden.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.03
- Investments by industry
- Biotechnology (1)
- Investments by region
-
- Sweden (1)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Group Appearance index
- 1.00
- Avg. company exit year
- 17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.